Hoth Therapeutics to buy up to $1 million worth of Bitcoin
Hoth Therapeutics, a publicly-traded biopharmaceutical company, has adopted Bitcoin (BTC) as a treasury asset. The clinical-stage biopharmaceutical company announced on Nov. 20 that its board of directors had approved adding BTC to its balance sheet. In the first step of this significant move, Hoth Therapeutics will buy up to $1 million in Bitcoin, according to details in a press release . Big move as Hoth buys Bitcoin Hoth points to Bitcoin’s traction as an investment asset, global adoption and rising institutional purchase as key to its decision. Bitcoin ETFs and options approval , increased ETF inflows and assets as well as plans for strategic BTC reserves has also buoyed several platforms. The Hoth management team also looked at BTC as a hedge against inflation and store of value as crucial features. “As Bitcoin continues to grow, gaining investor attention and acceptance as a major and primary asset class, we believe that Bitcoin will serve as a strong treasury reserve asset,...